Article
Increased Anti-Inflammatory Therapeutic Potential and Progenitor Marker Expression of Corneal Mesenchymal Stem Cells Cultured in an Optimized Propagation Medium.
Cell transplantation - 1 Jan 2024
Hopkinson Andrew, Notara Maria, Cursiefen Claus, Sidney Laura E
Abstract excerpt
There is a huge unmet need for new treatment modalities for ocular surface inflammatory disorders (OSIDs) such as dry eye disease and meibomian gland dysfunction. Mesenchymal stem cell therapies may hold the answer due to their potent immunomodulatory properties, low immunogenicity, and ability to modulate both the innate and adaptive immune response. MSC-like cells that can be isolated from the corneal stroma...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
